GR3015132T3 - Novel ureas and thioureas, preparation thereof and application in therapy. - Google Patents

Novel ureas and thioureas, preparation thereof and application in therapy.

Info

Publication number
GR3015132T3
GR3015132T3 GR950400352T GR950400352T GR3015132T3 GR 3015132 T3 GR3015132 T3 GR 3015132T3 GR 950400352 T GR950400352 T GR 950400352T GR 950400352 T GR950400352 T GR 950400352T GR 3015132 T3 GR3015132 T3 GR 3015132T3
Authority
GR
Greece
Prior art keywords
therapy
preparation
application
thioureas
novel ureas
Prior art date
Application number
GR950400352T
Other languages
English (en)
Inventor
Jean-Louis Vidaluc
Denis Bigg
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of GR3015132T3 publication Critical patent/GR3015132T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR950400352T 1991-02-14 1995-02-22 Novel ureas and thioureas, preparation thereof and application in therapy. GR3015132T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9101740A FR2672888B1 (fr) 1991-02-14 1991-02-14 Nouvelles urees et thiourees, leur preparation et leur application en therapeutique.
PCT/FR1992/000131 WO1992014710A1 (fr) 1991-02-14 1992-02-12 Nouvelles urees et thiourees, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
GR3015132T3 true GR3015132T3 (en) 1995-05-31

Family

ID=9409713

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950400352T GR3015132T3 (en) 1991-02-14 1995-02-22 Novel ureas and thioureas, preparation thereof and application in therapy.

Country Status (9)

Country Link
EP (1) EP0571511B1 (el)
JP (1) JPH06507387A (el)
AT (1) ATE115131T1 (el)
DE (1) DE69200840T2 (el)
DK (1) DK0571511T3 (el)
ES (1) ES2066605T3 (el)
FR (1) FR2672888B1 (el)
GR (1) GR3015132T3 (el)
WO (1) WO1992014710A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1604653A1 (en) 1998-09-30 2005-12-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
US6670364B2 (en) 2001-01-31 2003-12-30 Telik, Inc. Antagonists of MCP-1 function and methods of use thereof
US6962926B2 (en) 2001-01-31 2005-11-08 Telik, Inc. Antagonist of MCP-1 function, and compositions and methods of use thereof
TWI245761B (en) 2001-03-01 2005-12-21 Telik Inc Antagonists of MCP-1 function and methods of use thereof
US6677365B2 (en) * 2001-04-03 2004-01-13 Telik, Inc. Antagonists of MCP-1 function and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne

Also Published As

Publication number Publication date
FR2672888A1 (fr) 1992-08-21
DK0571511T3 (da) 1995-05-08
EP0571511A1 (fr) 1993-12-01
WO1992014710A1 (fr) 1992-09-03
DE69200840D1 (de) 1995-01-19
DE69200840T2 (de) 1995-06-29
ATE115131T1 (de) 1994-12-15
JPH06507387A (ja) 1994-08-25
EP0571511B1 (fr) 1994-12-07
FR2672888B1 (fr) 1994-02-04
ES2066605T3 (es) 1995-03-01

Similar Documents

Publication Publication Date Title
HU9303458D0 (en) Process for producing sulfonamides and pharmaceutical preparations containing them
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
EP1138673A3 (en) Novel carbamates and ureas as modifiers of multi-drug resistance
MY111201A (en) New imidazopyridines
AP9701041A0 (en) Pyridylpyrrole compounds.
AU1808488A (en) Compounds for the treatment of alzheimer's disease
RU94036748A (ru) Церамиды, способ их получения, композиция на их основе и способ гидратирующей обработки кожи или волос
MY109143A (en) Sulfonamido-and sulfonamidocarbonylpyridine 2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
ZA857274B (en) Diarylacetylenes,their preparation and their use
IL116122A0 (en) Intermediates to heterocyclic-cyclic amine derivatives
IL118889A (en) Pharmaceutical compositions containing n-(aroyl) glycine hydroxamic acid and related compounds and some such novel compounds
BR9507917A (pt) Reagente para preparar um agente radiofarmacêutico agente formador de imagem processo para preparar o mesmo kit para preparar uma preparação farmacêutica uso do reagente agente radioterapêutico composição e agente radiofarmacêutico
LTIP919A (en) Drugs and process for preparing thereof
HU9201288D0 (en) Kinoxalyne derivatives, process for their production and medical preparations containing them
HU904201D0 (en) Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds
PL313078A1 (en) Novel bis-naphtalimides for use in treating carcinoma
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
ES2066605T3 (es) Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica.
ES8707734A1 (es) Procedimiento para la obtencion de cefalosporinas
IL109151A0 (en) Pharmaceutical preparations for the treatment of skin disorders
NZ222045A (en) From diamides up to tetrapeptides for use as anticanvulsants
KR950011119B1 (en) Process for the manufacture of n,n-(di benzohexa trienylene)ureas
EP0487996A3 (en) Cephalosporins substituted in position 3, process for their preparation and their use as medicine
IL99236A0 (en) Pharmaceutical composition for the topical treatment of psoriasis